Rosalba Torrisi

2PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 27, 2022
Predictors of fulvestrant long-term benefit in hormone receptor-positive/HER2 negative advanced breast cancer.

Rosalba Torrisi, Valentina Vaira, Laura Giordano

|Aug 28, 2021
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9).

Rosalba Torrisi, Raffaella Palumbo, Rita De Sanctis

Pageof 1

Frequent Collaborators

2 joint publications

Armando Santoro

1 joint publications

Raffaella Palumbo

1 joint publications

Rita De Sanctis

1 joint publications

Patrizia Vici